{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:07:04Z","timestamp":1793383624252,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jcmg.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T14:39:53Z","timestamp":1689172793000},"page":"45-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-3188","authenticated-orcid":false,"given":"Ryota","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Sakuragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-7574","authenticated-orcid":false,"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachiyo","family":"Kuwatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-2052","authenticated-orcid":false,"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcmg.2023.05.017_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jcmg.2023.05.017_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcmg.2023.05.017_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jcmg.2023.05.017_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","author":"Slart","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2 pt 1","key":"10.1016\/j.jcmg.2023.05.017_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.jcmg.2023.05.017_bib7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18 F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.jcmg.2023.05.017_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jcmg.2023.05.017_bib9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC State-of-the-Art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jcmg.2023.05.017_bib10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.jcmg.2023.05.017_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1016\/j.jcmg.2023.05.017_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"18","key":"10.1016\/j.jcmg.2023.05.017_bib15","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2169\/internalmedicine.53.2491","article-title":"Visual findings of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with cardiac sarcoidosis","volume":"53","author":"Ito","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jcmg.2023.05.017_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.jcmg.2023.05.017_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105682","article-title":"A\u00a0semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT","volume":"9","author":"Hirata","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcmg.2023.05.017_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: the optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jcmg.2023.05.017_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jcmg.2023.05.017_bib21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"2 pt 2","key":"10.1016\/j.jcmg.2023.05.017_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18 F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"8","key":"10.1016\/j.jcmg.2023.05.017_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.jcmg.2023.05.017_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","article-title":"Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry","volume":"6","author":"Jefic","year":"2009","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.jcmg.2023.05.017_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jcmg.2023.05.017_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","article-title":"Treatment of cardiac sarcoidosis: a comparative study of steroids and steroids plus immunosuppressive drugs","volume":"276","author":"Ballul","year":"2019","journal-title":"Int J Cardiol"},{"issue":"8-9","key":"10.1016\/j.jcmg.2023.05.017_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.jcmg.2023.05.017_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jcmg.2023.05.017_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jcmg.2023.05.017_bib32","first-page":"520","article-title":"Japanese Antibacterial Drug Management for Cardiac Sarcoidosis (J-ACNES): a multicenter, open-label, randomized, controlled study","volume":"34","author":"Ishibashi","year":"2018","journal-title":"J\u00a0Arrhythm"},{"issue":"1","key":"10.1016\/j.jcmg.2023.05.017_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"4","key":"10.1016\/j.jcmg.2023.05.017_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X23002735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X23002735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:55:38Z","timestamp":1761846938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X23002735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1936878X23002735"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2023.05.017","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}